Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca v1.2 calcium channels

British Journal of Pharmacology

Volumn 160, Issue 7, 2010, Pages 1631-1640

  Zhang, Heng Yu ^a,b   Liao, Ping ^c   Wang, Jue Jin ^c   Yu, De Jie ^b   Soong, Tuck Wah ^b,c  

^a SICHUAN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

alternative splicing; calcium channel; diltiazem; heart; smooth muscle

Indexed keywords

CALCIUM CHANNEL; DILTIAZEM;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTROPHYSIOLOGY; EMBRYO; EXON; GENE LOCUS; HEART; HUMAN; HUMAN CELL; KIDNEY CELL; PATCH CLAMP; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; WHOLE CELL;

ACTION POTENTIALS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL LINE; CLONING, MOLECULAR; DILTIAZEM; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; PATCH-CLAMP TECHNIQUES;

EID: 77954323103     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00798.x     Document Type: Article

References (31)

1. Abernethy DR, Schwartz JB (1999). Calcium-antagonist drugs. N Engl J Med 341:1447 1457.
2. Alexander SPH, Mathie A, Peters JA (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
3. Budriesi R, Cosimelli B, Ioan P, Carosati E, Ugenti MP, Spisani R (2007). Diltiazem analogues: the last ten years on structure activity relationships. Curr Med Chem 14:279 287.
4. Diebold RJ, Koch WJ, Ellinor PT, Wang JJ, Muthuchamy M, Wieczorek DF et al. (1992). Mutually exclusive exon splicing of the cardiac calcium channel alpha 1 subunit gene generates developmentally regulated isoforms in the rat heart. Proc Natl Acad Sci USA 89:1497 1501.
5. Dilmac N, Hilliard N, Hockerman GH (2003). Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of cav1.2. Mol Pharmacol 64:491 501.
6. Gidh-Jain M, Huang B, Jain P, Battula V, el-Sherif N (1995). Reemergence of the fetal pattern of l-type calcium channel gene expression in noninfarcted myocardium during left ventricular remodeling. Biochem Biophys Res Commun 216:892 897.
7. Hadley RW, Lederer WJ (1991). Properties of l-type calcium channel gating current in isolated guinea pig ventricular myocytes. J Gen Physiol 98:265 285.
8. Hering S, Aczel S, Grabner M, Doring F, Berjukow S, Mitterdorfer J et al. (1996). Transfer of high sensitivity for benzothiazepines from l-type to class A (BI) calcium channels. J Biol Chem 271:24471 24475. (Pubitemid 26333182)
9. Herlitze S, Hockerman GH, Scheuer T, Catterall WA (1997). Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit. Proc Natl Acad Sci USA 94:1512 1516.
10. Hockerman GH, Dilmac N, Scheuer T, Catterall WA (2000). Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of l-type Ca(2+) channels. Mol Pharmacol 58:1264 1270.
11. Kraus RL, Hering S, Grabner M, Ostler D, Striessnig J (1998). Molecular mechanism of diltiazem interaction with l-type Ca2+ channels. J Biol Chem 273:27205 27212. (Pubitemid 28500430)
12. Lee KS, Tsien RW (1983). Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 302:790 794.
13. Liao P, Yu D, Lu S, Tang Z, Liang MC, Zeng S et al. (2004). Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels. J Biol Chem 279:50329 50335.
14. Liao P, Yong TF, Liang MC, Yue DT, Soong TW (2005). Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. Cardiovasc Res 68:197 203.
15. Liao P, Yu D, Li G, Yong TF, Soon JL, Chua YL et al. (2007). A smooth muscle Cav1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine. J Biol Chem 282:35133 35142.
16. Liao P, Li G, Yu DJ, Yong TF, Wang JJ, Wang J et al. (2009a). Molecular alteration of Ca(v)1.2 calcium channel in chronic myocardial infarction. Pflugers Arch 458:701 711.
17. Liao P, Zhang HY, Soong TW (2009b). Alternative splicing of voltage-gated calcium channels: from molecular biology to disease. Pflugers Arch 458:481 487.
18. Nelson MT, Standen NB, Brayden JE, Worley JF 3rd. (1988). Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature 336:382 385.
19. Ren D, Xu H, Eberl DF, Chopra M, Hall LM (1998). A mutation affecting dihydropyridine-sensitive current levels and activation kinetics in Drosophila muscle and mammalian heart calcium channels. J Neurosci 18:2335 2341.
20. Shen Y, Yu D, Hiel H, Liao P, Yue DT, Fuchs PA et al. (2006). Alternative splicing of the Ca(v)1.3 channel IQ domain, a molecular switch for Ca2+-dependent inactivation within auditory hair cells. J Neurosci 26:10690 10699.
21. Snutch TP, Tomlinson WJ, Leonard JP, Gilbert MM (1991). Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS. Neuron 7:45 57.
22. Soldatov NM (1994). Genomic structure of human l-type Ca2+ channel. Genomics 22:77 87.
23. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19 31.
24. Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT (2006). CACNA1H mutations in autism spectrum disorders. J Biol Chem 281:22085 22091.
25. Striessnig J (1999). Pharmacology, structure and function of cardiac l-type Ca(2+) channels. Cell Physiol Biochem 9:242 269.
26. Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H (1998). Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 19:108 115.
27. Sun J, Triggle DJ (1995). Calcium channel antagonists: cardiovascular selectivity of action. J Pharmacol Exp Ther 274:419 426.
28. Triggle DJ (2003). 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 23:293 303.
29. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F (1997). Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle l-type Ca2+ channels. Circ Res 81:526 532.
30. Zamponi GW, Soong TW, Bourinet E, Snutch TP (1996). Beta subunit coexpression and the alpha1 subunit domain I-II linker affect piperidine block of neuronal calcium channels. J Neurosci 16:2430 2443.
31. Zhang JF, Ellinor PT, Aldrich RW, Tsien RW (1994). Molecular determinants of voltage-dependent inactivation in calcium channels. Nature 372:97 100.